Search research articles
Contact Us
Filters
Showing results (121-130 of 146) with videos related to
Page
of 15
Sort By:
BMC Infectious Diseases
|
September 13, 2017
The Canadian HIV and aging cohort study - determinants of increased risk of cardio-vascular diseases in HIV-infected individuals: rationale and study protocol
Madeleine Durand, Carl Chartrand-Lefebvre, Jean-Guy Baril, et al.
Advances in Therapy
|
May 11, 2022
Safety and Effectiveness Using 8 Weeks of Glecaprevir/Pibrentasvir in HCV-Infected Treatment-Naïve Patients with Compensated Cirrhosis: The CREST Study
Markus Cornberg, Adriana Ahumada, Alessio Aghemo, et al.
BMC Infectious Diseases
|
June 5, 2013
Factors affecting antiretroviral pharmacokinetics in HIV-infected women with virologic suppression on combination antiretroviral therapy: a cross-sectional study
Mona Rafik Loutfy, Sharon Lynn Walmsley, Marina Barbara Klein, et al.
The International Journal on Drug Policy
|
June 19, 2017
Efficacy of response-guided directly observed pegylated interferon and self-administered ribavirin for people who inject drugs with hepatitis C virus genotype 2/3 infection: The ACTIVATE study
Jason Grebely, Olav Dalgard, Evan B Cunningham, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
January 16, 2023
Patient-Reported Outcomes During and After Hepatitis C Virus Direct-Acting Antiviral Treatment Among People Who Inject Drugs
Qinglu Cheng, Evan B Cunningham, Sophy Shih, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
July 14, 2019
Patterns of Drug and Alcohol Use and Injection Equipment Sharing Among People With Recent Injecting Drug Use or Receiving Opioid Agonist Treatment During and Following Hepatitis C Virus Treatment With Direct-acting Antiviral Therapies: An International Study
Andreea A Artenie, Evan B Cunningham, Gregory J Dore, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 3, 2019
Adherence to Once-daily and Twice-daily Direct-acting Antiviral Therapy for Hepatitis C Infection Among People With Recent Injection Drug Use or Current Opioid Agonist Therapy
Evan B Cunningham, Behzad Hajarizadeh, Janaki Amin, et al.
Plos One
|
July 14, 2022
A randomized control trial of high-dose micronutrient-antioxidant supplementation in healthy persons with untreated HIV infection
Wendy L Wobeser, Joanne E McBane, Louise Balfour, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 14, 2020
Reinfection Following Successful Direct-acting Antiviral Therapy for Hepatitis C Virus Infection Among People Who Inject Drugs
Evan B Cunningham, Behzad Hajarizadeh, Janaki Amin, et al.
BMC Infectious Diseases
|
June 15, 2017
Adherence to response-guided pegylated interferon and ribavirin for people who inject drugs with hepatitis C virus genotype 2/3 infection: the ACTIVATE study
Evan B Cunningham, Behzad Hajarizadeh, Olav Dalgard, et al.
Page
of 15
Search research articles
Search
Showing results (121-130 of 146) with videos related to
Sort By:
Page
of 15
BMC Infectious Diseases
|
September 13, 2017
The Canadian HIV and aging cohort study - determinants of increased risk of cardio-vascular diseases in HIV-infected individuals: rationale and study protocol
Madeleine Durand, Carl Chartrand-Lefebvre, Jean-Guy Baril, et al.
Advances in Therapy
|
May 11, 2022
Safety and Effectiveness Using 8 Weeks of Glecaprevir/Pibrentasvir in HCV-Infected Treatment-Naïve Patients with Compensated Cirrhosis: The CREST Study
Markus Cornberg, Adriana Ahumada, Alessio Aghemo, et al.
BMC Infectious Diseases
|
June 5, 2013
Factors affecting antiretroviral pharmacokinetics in HIV-infected women with virologic suppression on combination antiretroviral therapy: a cross-sectional study
Mona Rafik Loutfy, Sharon Lynn Walmsley, Marina Barbara Klein, et al.
The International Journal on Drug Policy
|
June 19, 2017
Efficacy of response-guided directly observed pegylated interferon and self-administered ribavirin for people who inject drugs with hepatitis C virus genotype 2/3 infection: The ACTIVATE study
Jason Grebely, Olav Dalgard, Evan B Cunningham, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
January 16, 2023
Patient-Reported Outcomes During and After Hepatitis C Virus Direct-Acting Antiviral Treatment Among People Who Inject Drugs
Qinglu Cheng, Evan B Cunningham, Sophy Shih, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
July 14, 2019
Patterns of Drug and Alcohol Use and Injection Equipment Sharing Among People With Recent Injecting Drug Use or Receiving Opioid Agonist Treatment During and Following Hepatitis C Virus Treatment With Direct-acting Antiviral Therapies: An International Study
Andreea A Artenie, Evan B Cunningham, Gregory J Dore, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 3, 2019
Adherence to Once-daily and Twice-daily Direct-acting Antiviral Therapy for Hepatitis C Infection Among People With Recent Injection Drug Use or Current Opioid Agonist Therapy
Evan B Cunningham, Behzad Hajarizadeh, Janaki Amin, et al.
Plos One
|
July 14, 2022
A randomized control trial of high-dose micronutrient-antioxidant supplementation in healthy persons with untreated HIV infection
Wendy L Wobeser, Joanne E McBane, Louise Balfour, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 14, 2020
Reinfection Following Successful Direct-acting Antiviral Therapy for Hepatitis C Virus Infection Among People Who Inject Drugs
Evan B Cunningham, Behzad Hajarizadeh, Janaki Amin, et al.
BMC Infectious Diseases
|
June 15, 2017
Adherence to response-guided pegylated interferon and ribavirin for people who inject drugs with hepatitis C virus genotype 2/3 infection: the ACTIVATE study
Evan B Cunningham, Behzad Hajarizadeh, Olav Dalgard, et al.
Page
of 15